These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Safety and efficacy of bupropion in elderly patients: preliminary observations.
    Author: Kane JM, Cole K, Sarantakos S, Howard A, Borenstein M.
    Journal: J Clin Psychiatry; 1983 May; 44(5 Pt 2):134-6. PubMed ID: 6406442.
    Abstract:
    The efficacy and safety of bupropion, an atypical antidepressant, were assessed in depressed patients aged 55 and above. Data were analyzed for 38 patients who completed 4 weeks of double-blind treatment with bupropion in maximum doses of 150 or 450 mg/day; imipramine, up to 200 mg/day; or placebo. Preliminary results suggest that bupropion does have antidepressant activity and is well tolerated in this population. A particular advantage is suggested in terms of cardiovascular side effects.
    [Abstract] [Full Text] [Related] [New Search]